The daily dietary intake of ochratoxin a — Results of a duplicate portion study with Bavarian schoolchildren

2003 ◽  
Vol 19 (1) ◽  
pp. 8-12 ◽  
Author(s):  
G. Engelhardt ◽  
R. Kibler ◽  
S. Verwied-Jorky ◽  
B. Koletzko
1994 ◽  
Vol 199 (4) ◽  
pp. 251-254 ◽  
Author(s):  
Harry J. Robberecht ◽  
Peter Hendrix ◽  
Rudy Cauwenbergh ◽  
Hendrik A. Deelstra

2008 ◽  
Vol 37 (3) ◽  
pp. 325-332 ◽  
Author(s):  
Jung-Duck Park ◽  
Ming-Ai Huang ◽  
Ruth Im ◽  
Byung-Sun Choi ◽  
Jae-Ho Yang ◽  
...  

Proceedings ◽  
2020 ◽  
Vol 70 (1) ◽  
pp. 84
Author(s):  
Rimjhim Agarwal ◽  
Hung T. Hong ◽  
Alice Hayward ◽  
Stephen Harper ◽  
Neena Mitter ◽  
...  

Age-related macular degeneration (AMD) is the leading cause of blindness in developed countries, such as Australia. Lutein and zeaxanthin are the only two carotenoids found in the macular region of the eye. Studies have shown that an intake of 10 mg and 2 mg per day of lutein and zeaxanthin, respectively, can reduce the rate of progression of AMD. The supply of these carotenoids can only be met through dietary sources or supplements, as these compounds cannot be synthesised by humans. Although lutein is relatively abundant in dietary sources, zeaxanthin has limited sources. In this study, eight orange and three red capsicum varieties were analysed for their carotenoid profiles by UHPLC-DAD-APCI-MS. It was observed that the principal carotenoid for seven of the orange varieties was zeaxanthin, and capsanthin for the three red varieties. One orange variety, which had a darker orange hue, had capsanthin and violaxanthin as its principal carotenoids instead of zeaxanthin. Zeaxanthin concentration (the principal carotenoid) in the seven orange varieties varied from 2.6 ± 0.5 mg/100 g to 25.27 ± 9.4 mg/100 FW, suggesting that as little as 7 g of the high-zeaxanthin line could meet the recommended daily dietary intake of 2 mg/person/day.


2008 ◽  
Vol 25 (8) ◽  
pp. 937-945 ◽  
Author(s):  
C. Velasco-Reynold ◽  
M. Navarro-Alarcon ◽  
H. López-GaDe La Serrana ◽  
M.C. Lopez-Martinez

1996 ◽  
Vol 184 (3) ◽  
pp. 183-189 ◽  
Author(s):  
J.P. Díaz-Alarcón ◽  
M. Navarro-Alarcón ◽  
H. López-García de la Serrana ◽  
M.C. López-Martínez

2016 ◽  
Vol 210 ◽  
pp. 135-140 ◽  
Author(s):  
Shahzad Zafar Iqbal ◽  
Muhammad Rafique Asi ◽  
Usman Hanif ◽  
Muhammad Zuber ◽  
S. Jinap
Keyword(s):  

2013 ◽  
Vol 2013 ◽  
pp. 1-9 ◽  
Author(s):  
Taha Rashid ◽  
Clyde Wilson ◽  
Alan Ebringer

Both ankylosing spondylitis (AS) and Crohn’s disease (CD) are chronic and potentially disabling interrelated conditions, which have been included under the group of spondyloarthropathies. The results of a large number of studies support the idea that an enteropathic pathogen,Klebsiella pneumoniae, is the most likely triggering factor involved in the initiation and development of these diseases. Increased starch consumptions by genetically susceptible individuals such as those possessing HLA-B27 allelotypes could trigger the disease in both AS and CD by enhancing the growth and perpetuation of theKlebsiellamicrobes in the bowel. Exposure to increased levels of these microbes will lead to the production of elevated levels of anti-Klebsiellaantibodies as well as autoantibodies against cross-reactive self-antigens with resultant pathological lesions in the bowel and joints. Hence, a decrease of starch-containing products in the daily dietary intake could have a beneficial therapeutic effect on the disease especially when used in conjunction with the currently available medical therapies in the treatment of patients with AS and CD.


Sign in / Sign up

Export Citation Format

Share Document